Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Re: Targeted Prostate Cancer Screening in BRCA1 or BRCA2 Pathogenic Germline Variant Carriers Detects Clinically Relevant Disease: Five-year Results of the IMPACT Study. Local targets link to admitted publications; unresolved targets remain external evidence.
Targeted prostate cancer screening in carriers of BRCA1 or BRCA2 pathogenic germline variants detects clinically relevant disease: 5-year results from the IMPACT study
10.1016/j.eururo.2026.01.031 · 2026 · External reference
Interim results from the Impact study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers
10.1016/j.eururo.2019.08.019 · 2019 · External reference
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer
10.1200/jco.2012.43.1882 · 2013 · External reference
EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent
10.1016/j.eururo.2024.03.027 · 2024 · External reference
The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study
10.1016/j.eururo.2021.08.002 · 2021 · External reference
